Conference Detail Page

Immunotherapy Strategies for the Treatment of Urothelial Cancer: Updates From September 2020

CME : 0.5
Start Date :  Dec 22 - 2020 End Date :  Dec 22 - 2021

Organized by :   Medscape, LLC

Specialities :   Immunotherapies, Oncology

Conference Summary

Immunotherapy Strategies for the Treatment of Urothelial Cancer: Updates From September 2020 is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 12/22/2020
Valid for credit through: 12/22/2021

Accreditation:
For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Goal Statement:
The goal of this activity is to update physicians on the latest clinical trial data from September 2020 on immunotherapies for the management of urothelial cancer.

Learning Objectives:
Upon completion of this activity, participants will:

• Have increased knowledge regarding the
○ Latest clinical trial data investigating immunotherapies in urothelial cancers
• Have greater competence related to
○ Interpreting the latest clinical trial data investigating immunotherapies in urothelial cancer

Credit Info

  • CME : 0.5
Target Audience

This educational activity is intended for an international audience of non-US hematologists, urologists, and pathologists.

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat